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Abstract

Original Article
IntroductIon
Streptococcus pneumoniae is a major cause of pneumonia and invasive disease worldwide. The World Health Organisation estimates that around 15 million invasive pneumococcal disease (IPD) cases result in approximately 500,000 deaths worldwide that occur annually in children aged <5 years, particularly in developing countries. [1] S. pneumoniae has been classified currently up to 98 serotypes based on the composition of its capsular polysaccharide, which is the major virulence factor. [2] S. pneumoniae shows serotype diversity with respect to age, geography and disease potential. [3] With the ability of natural transformation, S. pneumoniae has become highly recombinant undergoing intra-and inter-species recombination during its carriage in the nasopharynx. [4, 5] This has led to the exchange of capsule, virulence factors and antimicrobial resistance genes which caused challenges in identification and epidemiological characterisation. Thus, several molecular methods such as pulsed-field gel electrophoresis, [6] BOX typing, [7] ribotyping, [8] multilocus enzyme electrophoresis [9] and multilocus sequence typing (MLST) [10] were used for characterising S. pneumoniae. MLST is widely used due to its unambiguity and reproducibility combined with the advantage of comparable data worldwide.
Despite this serotype diversity, the majority of IPD are caused only by about 6 to 11 serotypes. [11] Pneumococcal conjugate vaccines (PCVs) are commonly designed based on these predominant serotypes. Vaccine introduction has led to the emergence of vaccine escape recombinants in developed countries. Vaccine escape recombinants are strains that have a non-vaccine serotype but the same sequence type (ST). Moreover, the disease potential depends on serotype as well as ST. [12] Worldwide, MLST data to date have recognised highly invasive clones associated with certain serotypes as well as antimicrobial resistance clones. Some of these multidrug-resistant clones have spread globally. [13] ST as well as serotype of the prevalent pneumococci have to be considered in the design of new vaccines. Although a significant reduction in IPD cases was observed in several countries after the introduction of PCV in the early 2000s, [14] [15] [16] [17] the implementation of PCV in the Indian immunisation schedule was implemented in 2017 in a phased manner. This study was initiated with the aim of characterising pneumococcal isolates using MLST: (1) to assess the baseline serotype and ST data for invasive and carriage isolates in India, (2) to determine the relationship between Indian STs and (3) to compare between the Indian and global STs in the pre-vaccine era.
materIals and methods
Bacterial isolates
Two hundred and twenty-one S. pneumoniae isolates of both invasive (n = 138) and non-invasive (n = 83) obtained from <5-year children were included in the study. 
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was performed by the VITEK 2 system for the following antibiotics: penicillin, cefotaxime, erythromycin and cotrimoxazole only for the invasive isolates. The results were interpreted based on the Clinical Laboratory Standards Institute guidelines.
Multilocus sequence typing
From the isolates, genomic DNA was extracted manually 
results
One thirty-eight invasive and 83 carriage isolates of S. pneumoniae were characterised. Among the 138 invasive isolates, 103 were from blood, 31 from cerebrospinal fluid and 4 from pleural fluid. Majority of the invasive strains were isolated from clinical cases of sepsis (n = 52), followed by meningitis (n = 53) and pneumonia (n = 28).
A total of 37 serotypes were identified among the 138 invasive isolates. The most common serotypes were 14, 6B, 19F, 6A and 23F. Among the 83 carriage isolates, a total of 21 different serotypes were found, of which the major serotypes were 19F, 6B, 6A, 23F, 23B and 15C. Among the IPD serotypes, the PCV13 serotype coverage was 75% (n = 103/138).
Penicillin and cefotaxime non-susceptibilities among the meningeal isolates were 45% and 19%, respectively. On the other hand, non-susceptibility to penicillin and cefotaxime was observed in only 2% of the non-meningeal isolates. In addition, resistance to erythromycin and trimethoprim/ sulphamethoxazole was 48% and 100%, respectively. Vaccine serotypes 14, 19F, 6B and 6A were found to be resistant to penicillin, cefotaxime and erythromycin. The only invasive non-vaccine serotype that was found to be associated with resistance to the above-mentioned drugs was 10A. 
Sequence type analysis
goeBURST analysis
goeBURST analysis was carried out to understand clonal relatedness between the Indian and global isolates. The analysis within the study ST shows three clonal complexes (CCs) and 45 singletons. The major CCs and STs associated with invasive and non-invasive STs within the study isolates are shown in Figure 2 . In comparison with global 800 CC profiles available in the S. pneumoniae PHYLOViZ database (http://www. phyloviz.net/), the study isolates spread across 36 CCs and 22 singletons. Furthermore, 54% of the total study isolates were associated with eight CCs (CC320, CC230, CC63, CC217, CC289, CC473, CC8164 and CC315). Geographically, majority of the STs observed in India were similar to the STs seen in Asia and Europe to a lesser extent in Africa. Within Asia, the Indian STs match with the Southeast Asian countries, mainly Thailand, Nepal and Bangladesh.
Phylogenetic analyses of Indian sequence types
Maximum likelihood phylogenetic tree constructed using concatenated MLST allele sequences (except ddl locus to reduce the diversity) revealed mainly seven sequence clusters (SCs). Among these, SC7, 1 and 6 comprise several novel STs that belong to the Pneumococcal Molecular Epidemiology Network (PMEN) CCs such as 230, 320 and Figure 3 ]. This is in accordance with the goeBURST observations. dIscussIon This is the first report to characterise a large number of invasive and carriage isolates of S. pneumoniae from India, both serotype and ST wise. The most common serotypes (19F, 6B, 14 and 6A) observed were similar to the earlier studies reported from India. [20] [21] [22] [23] Overall, 75% of the invasive and 54% of the carriage isolates belong to vaccine serotypes. Most of the vaccine serotypes were highly associated with ST of PMEN clones (68%) and the remaining were new novel clones (32%). The diverse non-vaccine serotypes observed in this study such as 10A, 15B and 23B were similar and serotypes such as 35A, 34 and 15C were different from the earlier reports. [24] [25] [26] [27] Interestingly, the only non-vaccine serotype with multidrug resistance observed in the invasive study collection belongs to serotype 10A, which is alarming.
MLST analysis revealed a higher (90/231; 39%) number of new STs compared to the previously reported. [21] More number of new STs were observed in carriage isolates (46/83) than in invasive (44/138), which reflects increased genetic diversity and continuously evolving carriage population. This is similar to the observation of Brueggmann et al. [12] Only STs that are related to PMEN clones (ST236, 271, 320, 90, 386, 5612, 1701 and 473) were seen both in invasive and carriage. Of these, ST63, ST236 and ST1701 had more number of isolates which corresponds to PMEN-resistant clones. The majority of the new STs were found to be the single-locus variants or double-locus variants of the PMEN clones that have been previously reported mainly in India and other Southeast Asian countries. Interestingly, a new combination of allelic profiles was more than new alleles, which indicates highly evolving pneumococcal clones. This attributes to the clonal expansion of the pre-existing clones or PMEN clones. Most of the study STs were similar to those found in South Asia and Africa. However, we observed that certain STs were specific to India; this includes ST874, ST5672, ST13585 and ST9597.
Further, whole-genome analysis should be performed on these isolates to define global pneumococcal SCs to understand vaccine-driven serotype replacement and antimicrobial resistance.
conclusIon
To conclude, most of the invasive isolates were of vaccine serotypes with penicillin non-susceptibility. STs among vaccine serotypes are highly evolving, which is of concern. The observed ST diversity is due to the expansion of pre-existing PMEN clones that are mainly CC320 (236 Taiwan 19F -14), CC63 (Sweden 15A-25) and CC230 (Denmark 14 -32).
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